BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 24280877)

  • 1. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials.
    Shen J; Zuo ZX; Mao AP
    Inflamm Bowel Dis; 2014 Jan; 20(1):21-35. PubMed ID: 24280877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.
    Derwa Y; Gracie DJ; Hamlin PJ; Ford AC
    Aliment Pharmacol Ther; 2017 Aug; 46(4):389-400. PubMed ID: 28653751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
    Naseer M; Poola S; Ali S; Samiullah S; Tahan V
    Curr Clin Pharmacol; 2020; 15(3):216-233. PubMed ID: 32164516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis.
    Ford AC; Bernstein CN; Khan KJ; Abreu MT; Marshall JK; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):590-9; quiz 600. PubMed ID: 21407179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of probiotics in the induction and maintenance of inflammatory bowel disease remission: a systematic review and meta-analysis.
    Chen M; Feng Y; Liu W
    Ann Palliat Med; 2021 Nov; 10(11):11821-11829. PubMed ID: 34872306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.
    Khan KJ; Ullman TA; Ford AC; Abreu MT; Abadir A; Marshall JK; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):661-73. PubMed ID: 21407187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics combined with aminosalicylic acid affiliates remission of ulcerative colitis: a meta-analysis of randomized controlled trial.
    Peng L; Zhong Y; Wang A; Jiang Z
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30224379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics.
    Kruis W
    Dig Dis; 2013; 31(3-4):385-7. PubMed ID: 24246993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
    Khan KJ; Dubinsky MC; Ford AC; Ullman TA; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):630-42. PubMed ID: 21407186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
    Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
    Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Probiotics in chronic inflammatory bowel disease].
    Böhm S; Kruis W
    MMW Fortschr Med; 2006 Aug; 148(35-36):30-4. PubMed ID: 16995360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for inducing and maintaining remission in pouchitis.
    Sandborn W; McLeod R; Jewell D
    Cochrane Database Syst Rev; 2000; (2):CD001176. PubMed ID: 10796613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases.
    Chapman TM; Plosker GL; Figgitt DP
    Drugs; 2006; 66(10):1371-87. PubMed ID: 16903771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
    Ford AC; Sandborn WJ; Khan KJ; Hanauer SB; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):644-59, quiz 660. PubMed ID: 21407183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
    Holubar SD; Cima RR; Sandborn WJ; Pardi DS
    Cochrane Database Syst Rev; 2010 Jun; (6):CD001176. PubMed ID: 20556748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis.
    Dang X; Xu M; Liu D; Zhou D; Yang W
    PLoS One; 2020; 15(3):e0228846. PubMed ID: 32182248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics, probiotics and prebiotics in IBD.
    Bernstein CN
    Nestle Nutr Inst Workshop Ser; 2014; 79():83-100. PubMed ID: 25227297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics and remission of ulcerative colitis: a systematic review.
    Zigra PI; Maipa VE; Alamanos YP
    Neth J Med; 2007 Dec; 65(11):411-8. PubMed ID: 18079563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotic treatments for induction and maintenance of remission in inflammatory bowel diseases: a meta-analysis of randomized controlled trials.
    Fujiya M; Ueno N; Kohgo Y
    Clin J Gastroenterol; 2014 Feb; 7(1):1-13. PubMed ID: 26183502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease.
    Ghouri YA; Richards DM; Rahimi EF; Krill JT; Jelinek KA; DuPont AW
    Clin Exp Gastroenterol; 2014; 7():473-87. PubMed ID: 25525379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.